Towa Pharmaceutical Co., Ltd. TWAPF

Set alert

Price alert · TWAPF

All alert types
25.98 USD 0.00 0.00%

At close · Oct 29

26.00 Day range 26.00
16.83 52-week range 26.00
YTD
+54.37%
1 year
+54.37%
Open
26.00
Prev close
25.98
Mkt cap
1.28B
Vol
100
Avg vol
0
EPS
1.09
P/E
23.83
More statistics
Low
26.00
High
26.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TWAPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.09 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 3
  • P/B 5

Valuation

P/E 25.0×
FY 2017: 52.1×FY 2018: 46.2×FY 2019: 23.3×FY 2020: 19.3×FY 2021: 20.7×FY 2022: 9.2×FY 2023: 72.3×FY 2024: 11.2×FY 2025: 9.5×FY 2026: 25.0×
FY 2017 5y median 11.2× FY 2026
P/S 0.5×
FY 2017: 3.4×FY 2018: 3.2×FY 2019: 3.0×FY 2020: 2.5×FY 2021: 1.9×FY 2022: 0.9×FY 2023: 0.8×FY 2024: 0.8×FY 2025: 0.7×FY 2026: 0.5×
FY 2017 5y median 0.8× FY 2026
P/B 0.7×
FY 2017: 3.9×FY 2018: 3.8×FY 2019: 3.4×FY 2020: 2.7×FY 2021: 2.5×FY 2022: 1.1×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 1.0×FY 2026: 0.7×
FY 2017 5y median 1.1× FY 2026
P/FCF 16.0×
FY 2017: -26.5×FY 2018: 77.7×FY 2019: 41.0×FY 2020: 19.3×FY 2021: 136×FY 2022: 17.0×FY 2023: -5.7×FY 2024: -5.8×FY 2025: -23.0×FY 2026: 16.0×
FY 2017 5y median -5.7× FY 2026
EV/EBITDA 6.8×
FY 2017: 22.5×FY 2018: 19.6×FY 2019: 12.9×FY 2020: 11.8×FY 2021: 11.5×FY 2022: 8.7×FY 2023: 12.4×FY 2024: 8.2×FY 2025: 7.6×FY 2026: 6.8×
FY 2017 5y median 8.2× FY 2026
EV/Sales 1.1×
FY 2017: 4.1×FY 2018: 3.8×FY 2019: 3.4×FY 2020: 3.1×FY 2021: 2.3×FY 2022: 1.6×FY 2023: 1.5×FY 2024: 1.6×FY 2025: 1.4×FY 2026: 1.1×
FY 2017 5y median 1.5× FY 2026
FCF Yield 6.2%
FY 2017: -3.8%FY 2018: 1.3%FY 2019: 2.4%FY 2020: 5.2%FY 2021: 0.7%FY 2022: 5.9%FY 2023: -17.6%FY 2024: -17.1%FY 2025: -4.4%FY 2026: 6.2%
FY 2017 5y median -4.4% FY 2026

Profitability

Gross Margin 36.2%
FY 2017: 46.0%FY 2018: 46.1%FY 2019: 46.0%FY 2020: 45.9%FY 2021: 42.3%FY 2022: 42.4%FY 2023: 34.8%FY 2024: 35.7%FY 2025: 36.5%FY 2026: 36.2%
FY 2017 5y median 36.2% FY 2026
Operating Margin 8.4%
FY 2017: 8.1%FY 2018: 12.5%FY 2019: 15.2%FY 2020: 14.6%FY 2021: 12.9%FY 2022: 11.6%FY 2023: 2.6%FY 2024: 7.7%FY 2025: 9.0%FY 2026: 8.4%
FY 2017 5y median 8.4% FY 2026
Net Margin 1.9%
FY 2017: 6.6%FY 2018: 7.0%FY 2019: 12.8%FY 2020: 13.1%FY 2021: 9.0%FY 2022: 9.6%FY 2023: 1.1%FY 2024: 7.1%FY 2025: 7.3%FY 2026: 1.9%
FY 2017 5y median 7.1% FY 2026
ROE 2.9%
FY 2017: 7.4%FY 2018: 8.1%FY 2019: 14.7%FY 2020: 13.9%FY 2021: 12.0%FY 2022: 12.0%FY 2023: 1.6%FY 2024: 10.4%FY 2025: 11.1%FY 2026: 2.9%
FY 2017 5y median 10.4% FY 2026
ROIC 2.3%
FY 2017: 3.7%FY 2018: 5.0%FY 2019: 7.1%FY 2020: 6.0%FY 2021: 7.2%FY 2022: 4.9%FY 2023: 0.8%FY 2024: 3.2%FY 2025: 4.1%FY 2026: 2.3%
FY 2017 5y median 3.2% FY 2026
ROA 1.1%
FY 2017: 3.4%FY 2018: 3.7%FY 2019: 7.1%FY 2020: 6.4%FY 2021: 5.7%FY 2022: 4.8%FY 2023: 0.6%FY 2024: 3.8%FY 2025: 4.0%FY 2026: 1.1%
FY 2017 5y median 3.8% FY 2026

Growth (YoY)

Revenue 6.1%
FY 2017: 3.5%FY 2018: 10.0%FY 2019: 12.5%FY 2020: 5.0%FY 2021: 40.3%FY 2022: 6.9%FY 2023: 26.1%FY 2024: 9.1%FY 2025: 13.9%FY 2026: 6.1%
FY 2017 FY 2026
Operating Income 0.0%
FY 2017: -38.3%FY 2018: 69.5%FY 2019: 37.1%FY 2020: 1.1%FY 2021: 23.4%FY 2022: -3.6%FY 2023: -71.3%FY 2024: 220.0%FY 2025: 31.7%FY 2026: 0.0%
FY 2017 FY 2026
EPS (diluted) -72.2%
FY 2017: -28.0%FY 2018: 16.5%FY 2019: 107.6%FY 2020: 7.6%FY 2021: -0.2%FY 2022: 16.3%FY 2023: -85.9%FY 2024: 634.8%FY 2025: 17.4%FY 2026: -72.2%
FY 2017 FY 2026
Free Cash Flow 204.9%
FY 2017: -5.7%FY 2018: 135.1%FY 2019: 98.3%FY 2020: 89.5%FY 2021: -85.3%FY 2022: 301.7%FY 2023: -426.5%FY 2024: -11.4%FY 2025: 74.9%FY 2026: 204.9%
FY 2017 FY 2026

Financial Health

Current Ratio 2.8×
FY 2017: 2.5×FY 2018: 2.7×FY 2019: 2.9×FY 2020: 1.7×FY 2021: 2.7×FY 2022: 1.5×FY 2023: 2.3×FY 2024: 2.7×FY 2025: 2.8×FY 2026: 2.8×
FY 2017 5y median 2.7× FY 2026
Quick Ratio 1.5×
FY 2017: 1.4×FY 2018: 1.6×FY 2019: 1.9×FY 2020: 1.0×FY 2021: 1.5×FY 2022: 0.8×FY 2023: 1.1×FY 2024: 1.5×FY 2025: 1.6×FY 2026: 1.5×
FY 2017 5y median 1.5× FY 2026
Debt / Equity 1.3×
FY 2017: 0.9×FY 2018: 0.9×FY 2019: 0.7×FY 2020: 0.8×FY 2021: 0.7×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 1.3×FY 2025: 1.3×FY 2026: 1.3×
FY 2017 5y median 1.3× FY 2026
Net Debt / EBITDA 3.9×
FY 2017: 3.6×FY 2018: 3.1×FY 2019: 1.5×FY 2020: 2.2×FY 2021: 2.0×FY 2022: 3.8×FY 2023: 6.0×FY 2024: 4.0×FY 2025: 3.9×FY 2026: 3.9×
FY 2017 5y median 3.9× FY 2026
Interest Coverage 10.2×
FY 2017: 41.9×FY 2018: 73.7×FY 2019: 109×FY 2020: 123×FY 2021: 105×FY 2022: 83.5×FY 2023: 8.7×FY 2024: 18.6×FY 2025: 14.3×FY 2026: 10.2×
FY 2017 5y median 14.3× FY 2026

Dividends

Dividend Yield 3.0%
FY 2017: 0.5%FY 2018: 0.5%FY 2019: 0.6%FY 2020: 0.7%FY 2021: 0.8%FY 2022: 1.7%FY 2023: 1.9%FY 2024: 1.6%FY 2025: 1.6%FY 2026: 3.0%
FY 2017 5y median 1.7% FY 2026
Payout Ratio 75.0%
FY 2017: 27.9%FY 2018: 24.0%FY 2019: 14.1%FY 2020: 14.3%FY 2021: 15.5%FY 2022: 15.2%FY 2023: 140.8%FY 2024: 18.3%FY 2025: 15.6%FY 2026: 75.0%
FY 2017 5y median 18.3% FY 2026

Annual · latest fiscal year ends 2026-03-31